[Significance of adrenergic receptor blockade in the treatment of shock].
D000317:Adrenergic alpha-Antagonists / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D002196:Capillaries / Q000187:drug effects; D002395:Catecholamines / Q000009:adverse effects / Q000097:blood; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D000860:Hypoxia; D007668:Kidney / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008833:Microcirculation; D010949:Plasma / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D012769:Shock / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects; D014690:Venous Pressure / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011433:Propranolol
Znaczenie blokady receptorów adrenergicznych w leczeniu wstrzasu.